
Monobrite S 250mg/125mg Injection
Marketer
Zovaitalia Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Monobrite S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial growth and proliferation. Administered solely under medical guidance, this injection requires adherence to the prescribed dosage schedule. Complete the full course of treatment, regardless of symptom improvement, as premature cessation may compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening symptoms or allergic reactions (e.g., rash, itching, swelling, respiratory distress) immediately. Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or dizziness. Adequate rest, balanced nutrition, and hydration are crucial for optimal recovery. Your physician may order lab tests to monitor the treatment's efficacy.
Primary Ingredients of Monobrite S 250mg/125mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Monobrite S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Monobrite S 250mg/125mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Monobrite S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Monobrite S 250mg/125mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Monobrite S 250mg/125mg Injection works:
Ceftriaxone/Sulbactam injection (Monobrite S 250mg/125mg) combines a cephalosporin antibiotic, Ceftriaxone, with the beta-lactamase inhibitor, Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their survival. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Monobrite S 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Monobrite S (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal to no negative impacts on fetal development; however, corresponding data from human studies remain scarce.
Breast feedingCAUTION
Administering Monobrite S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Monobrite S 250mg/125mg Injection might reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Monobrite S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable medication, Monobrite S 250mg/125mg, requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alterations for Monobrite S 250mg/125mg Injection are not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Monobrite S 250mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Monobrite S 250mg/125mg Injection, seek immediate medical advice.
Facts to Know About Monobrite S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
